08:23pm PRESS DIGEST-Financial Times - September 7 RE
09-06 Novartis' Pelacarsen Misses Primary Endpoint in Late-stage Cardiovascular Outcomes Study MT
09-04 Novartis Pelacarsen Fails Phase III Cardiovascular Outcomes Trial MT
09-04 Novartis Says Pelacarsen Heart Disease Drug Missed Primary Endpoint -- 2nd Update DJ
09-04 Novartis, Ionis' experimental heart drug misses key goal in closely watched trial RE
09-04 Stocks to Watch : Ionis Pharmaceuticals, Novartis, Corvex DJ
09-04 Novartis Says Pelacarsen Heart Disease Drug Missed Primary Endpoint -- Update DJ
09-04 Novartis Says Pelacarsen Heart Disease Drug Missed Primary Endpoint DJ
09-04 Ionis-Novartis heart drug misses main goal of late-stage trial RE
09-04 RBC Expects New Midterm Targets from Sandoz at Upcoming Capital Markets Day MT
09-04 WISeKey International Joins Hedera Council as Strategic Partner MT
09-04 ABB to upgrade a nuclear power plant in Romania Zonebourse
09-04 Morgan Stanley Downgrades Kuehne+Nagel to Underweight, Lifts PT MT
09-04 Investors Watching Every Data Point: Haefele MT
09-04 Aevis Victoria Shareholders Sell Shares to Institutional Investor MT
09-04 Swiss stocks - Factors to watch on September 4 RE
09-03 Swiss Life Issues EUR600 Million Hybrid Bond MT
09-03 Anthropic Set to Finalize $15 Billion Credit Line Ahead of IPO MT
09-03 Amrize Insider Bought Shares Worth $1,274,080, According to a Recent SEC Filing MT
09-03 ABB Secures Project to Extend Operational Life of Romanian Nuclear Power Plant MT
09-03 ABB Bags Electrical Infrastructure Project from LKAB in Sweden MT
09-03 Strong Q2 Economic Growth Lifts Swiss Stocks; Givaudan Rises MT
09-03 UBS Sees Canada Employment Growth Slowing Sharply in August MT
09-03 UBS Faces Fresh Questions from US Senate Over Credit Suisse Nazi-Linked Accounts MT
09-03 Alcon Announces Initial Launch of UNITY M Surgical Microscope in US, Japan MT
No results match your criteria